Posted by Michael Wonder on 22 Jan 2024
PHARMAC publishes agenda for next month's PTAC meeting
18 January 2024 - Surprise, surprise yet another underwhelming agenda.
The agenda for next month's PTAC meeting has been published. Yet again, there is no application for a cancer medicine.
- Vedolizumab - restriction change
- Esketamine hydrochloride - new medicine
- PDE inhibitors - restriction change
- Naloxone hydrochloride - new formulation
- Faricimab - new medicine (2 indications)
